Chemify - About the company
Chemify is a series B company based in Glasgow (United Kingdom), founded in 2020 by Lee Cronin. It operates as a Developer of a platform for digitizing chemistry and chemical discovery. Chemify has raised $93M in funding from investors like Insight Partners, Wing Venture Capital and Triatomic. The company has 286 active competitors, including 87 funded and 15 that have exited. Its top competitors include companies like Schrodinger, Relay Therapeutics and XtalPi.
Company Details
Developer of a platform for digitizing chemistry and chemical discovery. The platform combines chemistry, robotics, computation, machine learning, and a programming language to automate molecule creation. It aims to accelerate molecular discovery and bridge the gap between design and synthesis. The company focuses on developing novel compounds and materials.
- Website
- www.chemify.io/
- Social
- Email ID
- *****@chemify.io
- Registered Address
- SCHOOL OF CHEMISTRY,UNIVERSITY OF GLASGOW,GLASGOW,SCOTLAND,G12 8QQ
Key Metrics
Founded Year
2020
Location
Glasgow, United Kingdom
Stage
Series B
Total Funding
$93M in 6 rounds
Latest Funding Round
Investors
Ranked
15th among 286 active competitors
Employee Count
212 as on Sep 30, 2026
Similar Companies
Legal entities associated with Chemify
Chemify is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Chemify Limited CIN: SC645290 , United Kingdom, Active | Oct 23, 2019 | - | - |
Sign up to download Chemify's company profile
Chemify's funding and investors
Chemify has raised a total funding of $93M over 6 rounds. Its first funding round was on Aug 02, 2023. Its latest funding round was a Grant (prize money) round on Sep 17, 2026 for $*****. 2 investors participated in its latest round. Chemify has 16 institutional investors.
Here is the list of recent funding rounds of Chemify:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 17, 2026 | 7686161 | Grant (prize money) | 7351594 | 6753375 | 7455361 | 4475828 |
Feb 12, 2026 | 7985559 | Series B | 4257764 | 4136220 | 6172153 | |
Dec 10, 2025 | 7465426 | Grant (prize money) | 7187090 | 2873978 | 3519245 |
Access funding benchmarks and valuations. Sign up today!View details of Chemify's funding rounds and investors
Chemify's founders and board of directors
Founder? Claim ProfileThe founders of Chemify is Lee Cronin. Lee Cronin is the CEO of Chemify.
Here are the details of Chemify's key team members:
- Lee Cronin: Founder & CEO of Chemify and founder of 1 other company. They serve on the board of 1 company.Contact Info: 1 email address
Chemify's Board of Directors
Chemify's board has 3 active members. Lee Cronin is part of team and Steven Hochberg and David Cleevely are independent board members.Here is the list of Chemify's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 6y 11m | |
Independent board member | - | Current | 3y 7m | |
bbpnwvf | Independent board member | - | Current | 9y 7m |
dabiybm | Independent board member | - | Past | 7y 4m |
View details of Chemify's Founder profiles and Board Members
Chemify's employee count trend
Chemify has 212 employees as of Sep 26. Here is Chemify's employee count trend over the years:
Uncover Chemify's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Chemify's Competitors and alternates
Top competitors of Chemify include Schrodinger, Relay Therapeutics and XtalPi. Here is the list of Top 10 competitors of Chemify, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Schrodinger 1990, New York City (United States), Acquired | Provider of a web-based simulation and modelling tool | $162M | 72/100 | |
2nd | Relay Therapeutics 2016, Cambridge (United States), Public | Developer of drug discovery platform and study protein motion | $520M | 69/100 | |
3rd |  XtalPi 2014, Cambridge (United States), Public | AI-based drug research and development company | $785M | 69/100 | |
4th |  Valo Health 2019, Boston (United States), Series B | AI-powered platform for drug discovery and development | $450M | 69/100 | |
5th |  Atomwise 2012, San Francisco (United States), Series B | Developer of artificial intelligence platform for small molecule drug discovery | $219M | 67/100 | |
6th |  Xaira 2023, San Francisco (United States), Series D | AI-enabled platform for drug discovery and development | $1B | 65/100 | |
7th |  Tandem AI 2021, New York (United States), Series A | AI-based drug discovery tool for researchers | $82M | 64/100 | |
8th | Recursion Pharmaceuticals 2013, New York (United States), Public | AI-enabled drug discovery and development platform for novel therapeutics | $452M | 64/100 | |
9th | Provider of an AI and quantum physics to discover therapeutic molecules | $101M | 63/100 | ||
10th |  In Silico 2014, Boston (United States), Public | AI-enabled bioinformatics platform for drug discovery and biomarker development | $510M | 63/100 | |
15th |  Chemify 2020, Glasgow (United Kingdom), Series B | Developer of a platform for digitizing chemistry and chemical discovery | $93M | 61/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Chemify's competitors? Click here to see the top ones
Chemify's Investments and acquisitions
Chemify has made no investments or acquisitions yet.
Reports related to Chemify
Here is the latest report on Chemify's sector:
News related to Chemify
Filter this listMedia has covered Chemify for a total of 7 events in the last 1 year, 1 of them has been about partnerships.
•
Chemify Receives £22M in Grants to Fund Expansion and Advance AI PlatformFinSMEs•Sep 17, 2026•Chemify, Scottish Enterprise
•
Chemify and Sanacor Collaborate to Discover and Develop Small Molecule Therapies for Cardiometabolic DiseasesBusiness Wire•Feb 25, 2026•Chemify, Sanacor
•
•
Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for TuberculosisBusiness Wire•Dec 10, 2025•Chemify, Gates
•
Glasgow's Chemify secures €43M to digitize molecule creation using AISilicon Canals•Oct 22, 2025•Chemify, Insight Partners, Wing Venture Capital
•
Chemify raises over $50M Series B to scale its ‘chemputers’ for AI ManufacturingEndpoints•Oct 21, 2025•Chemify, Insight Partners, Wing Venture Capital
•
Former Apple And Intel Executive Michael Bell Joins Chemify As Chief Technology OfficerBusiness Wire•Feb 27, 2025•Chemify, Apple, Intel
•
Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating OfficerBusiness Wire•Jan 10, 2025•Chemify
•
•
Chemify Hires Kevin McGowan as Chief Business Officer to Scale Commercial and Business Growth of Digital Chemistry TechnologyBusiness Wire•Aug 14, 2024•Chemify
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Chemify
Explore our recently published companies
- Artikel Zeiten - Germany based, Unfunded company
- Zeosan - Germany based, Unfunded company
- MySimpleLead - Unfunded company
- Edu Systems - 2021 founded, Unfunded company
- Go Human - Brazil based, 2020 founded, Unfunded company
- Tusman Studio - Unfunded company
